OXYMETAZOLINE HYDROCHLORIDE OPHTHALMIC

OXYMETAZOLINE HYDROCHLORIDE OPHTHALMIC was reported 2364 times

These side effects are most commonly reported by patients taking OXYMETAZOLINE HYDROCHLORIDE OPHTHALMIC:

# Side effect Count
0 DRUG INEFFECTIVE 618
1 VISION BLURRED 311
2 EYE IRRITATION 276
3 OCULAR HYPERAEMIA 257
4 OFF LABEL USE 199
5 HEADACHE 197
6 DRY EYE 186
7 EYE PAIN 183
8 MYDRIASIS 130
9 EYE PRURITUS 119
10 LACRIMATION INCREASED 90
11 SWELLING OF EYELID 88
12 EYE SWELLING 70
13 DIZZINESS 59
14 BLOOD PRESSURE INCREASED 50
15 OCULAR DISCOMFORT 45
16 THERAPEUTIC PRODUCT EFFECT DECREASED 43
17 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 43
18 MULTIPLE USE OF SINGLE-USE PRODUCT 38
19 DRUG EFFECT LESS THAN EXPECTED 37
20 PHOTOPHOBIA 36
21 ERYTHEMA OF EYELID 35
22 FOREIGN BODY SENSATION IN EYES 35
23 EYE DISCHARGE 34
24 EYELID DISORDER 33
25 ABNORMAL SENSATION IN EYE 28
26 ASTHENOPIA 28
27 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 28
28 VISUAL IMPAIRMENT 27
29 EYELID PTOSIS 26
30 MIGRAINE 24
31 BLEPHAROSPASM 23
32 EYELID IRRITATION 23
33 NAUSEA 23
34 EYELID OEDEMA 22
35 PALPITATIONS 22
36 PRODUCT USE IN UNAPPROVED INDICATION 22
37 EYELID PAIN 21
38 PERIORBITAL SWELLING 21
39 HORDEOLUM 20
40 HYPERSENSITIVITY 20
41 PRODUCT ADMINISTRATION ERROR 19
42 BLEPHARITIS 18
43 EYE DISORDER 18
44 SWELLING FACE 18
45 VITREOUS FLOATERS 18
46 DIPLOPIA 15
47 EYELID FUNCTION DISORDER 15
48 HEART RATE INCREASED 15
49 PRURITUS 15
50 CONDITION AGGRAVATED 14
51 EYELID MARGIN CRUSTING 14
52 MALAISE 14
53 EXPIRED PRODUCT ADMINISTERED 13
54 EYE INFECTION 13
55 EYE INFLAMMATION 13
56 RASH 12
57 URTICARIA 12
58 CONJUNCTIVAL HAEMORRHAGE 11
59 ERYTHEMA 11
60 INTENTIONAL PRODUCT MISUSE 11
61 PAIN 11
62 PRODUCT USE ISSUE 11
63 RHINORRHOEA 11
64 DRUG HYPERSENSITIVITY 10
65 INSOMNIA 10
66 ANXIETY 9
67 ASTHENIA 9
68 CONJUNCTIVITIS 9
69 DRY MOUTH 9
70 EYE HAEMORRHAGE 9
71 EYELIDS PRURITUS 9
72 INCORRECT DOSE ADMINISTERED 9
73 INSTILLATION SITE PAIN 9
74 CHEST DISCOMFORT 8
75 FATIGUE 8
76 FEELING JITTERY 8
77 HYPERTENSION 8
78 PARAESTHESIA 8
79 PERIORBITAL PAIN 8
80 PHOTOPSIA 8
81 ADVERSE EVENT 7
82 CATARACT 7
83 DIARRHOEA 7
84 MADAROSIS 7
85 RASH PRURITIC 7
86 WEIGHT DECREASED 7
87 ACCIDENTAL OVERDOSE 6
88 ADVERSE DRUG REACTION 6
89 DISCOMFORT 6
90 DYSGEUSIA 6
91 DYSPNOEA 6
92 EXCESSIVE EYE BLINKING 6
93 HALO VISION 6
94 INTRAOCULAR PRESSURE INCREASED 6
95 TACHYCARDIA 6
96 THERAPEUTIC PRODUCT EFFECT VARIABLE 6
97 VITREOUS DETACHMENT 6
98 VOMITING 6
99 ABDOMINAL DISCOMFORT 5
100 ADVERSE REACTION 5
101 BLINDNESS 5
102 BLOOD PRESSURE SYSTOLIC INCREASED 5
103 DEVICE PHYSICAL PROPERTY ISSUE 5
104 EMOTIONAL DISTRESS 5
105 EYELID SKIN DRYNESS 5
106 FALL 5
107 FEELING ABNORMAL 5
108 HYPOTENSION 5
109 INTENTIONAL PRODUCT USE ISSUE 5
110 MUSCULAR WEAKNESS 5
111 NASAL CONGESTION 5
112 NECK PAIN 5
113 RETINAL DETACHMENT 5
114 RETINAL TEAR 5
115 SKIN DISCOLOURATION 5
116 THERAPEUTIC RESPONSE UNEXPECTED 5
117 VERTIGO 5
118 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5
119 BALANCE DISORDER 4
120 CATARACT OPERATION 4
121 CHALAZION 4
122 CHILLS 4
123 DISTURBANCE IN ATTENTION 4
124 DYSPHAGIA 4
125 EYELID EXFOLIATION 4
126 FACIAL PAIN 4
127 HYPERHIDROSIS 4
128 HYPOAESTHESIA 4
129 HYPOAESTHESIA ORAL 4
130 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4
131 MACULAR DEGENERATION 4
132 METAMORPHOPSIA 4
133 MIGRAINE WITH AURA 4
134 ORTHOSTATIC HYPOTENSION 4
135 PARANASAL SINUS DISCOMFORT 4
136 PRODUCT STORAGE ERROR 4
137 SCLERAL DISCOLOURATION 4
138 SKIN EXFOLIATION 4
139 THERAPEUTIC RESPONSE SHORTENED 4
140 TINNITUS 4
141 TREMOR 4
142 VITREOUS HAEMORRHAGE 4
143 BACK PAIN 3
144 BLOOD GLUCOSE INCREASED 3
145 CONCOMITANT DISEASE AGGRAVATED 3
146 COUGH 3
147 DACRYOSTENOSIS ACQUIRED 3
148 DEAFNESS PERMANENT 3
149 DEHYDRATION 3
150 DEVICE COLOUR ISSUE 3
151 DISABILITY 3
152 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3
153 DRY THROAT 3
154 ECONOMIC PROBLEM 3
155 EPISTAXIS 3
156 EXOPHTHALMOS 3
157 EYELID CYST 3
158 GAIT DISTURBANCE 3
159 HOT FLUSH 3
160 HYPOPHAGIA 3
161 ILLNESS 3
162 INCORRECT DOSAGE ADMINISTERED 3
163 INCORRECT DRUG ADMINISTRATION RATE 3
164 INJURY 3
165 LIMB DISCOMFORT 3
166 MUSCLE SPASMS 3
167 MUSCLE TIGHTNESS 3
168 NASAL DISCOMFORT 3
169 PAROSMIA 3
170 PHOTOSENSITIVITY REACTION 3
171 PHYSICAL DISABILITY 3
172 PRESYNCOPE 3
173 PYREXIA 3
174 SEASONAL ALLERGY 3
175 SKIN IRRITATION 3
176 SKIN TIGHTNESS 3
177 SYNCOPE 3
178 TENSION HEADACHE 3
179 THERAPEUTIC PRODUCT EFFECT INCREASED 3
180 THERAPEUTIC PRODUCT EFFECT PROLONGED 3
181 ABDOMINAL PAIN UPPER 2
182 AMNESIA 2
183 ARTHRALGIA 2
184 ATRIAL FIBRILLATION 2
185 BLINDNESS UNILATERAL 2
186 BLOOD CREATININE INCREASED 2
187 BLOOD GLUCOSE ABNORMAL 2
188 BLOOD GLUCOSE DECREASED 2
189 BLOOD PRESSURE DECREASED 2
190 BRAIN FOG 2
191 CARDIAC FLUTTER 2
192 CELLULITIS 2
193 CONJUNCTIVAL HYPERAEMIA 2
194 CONSTIPATION 2
195 CONTUSION 2
196 CORNEAL ABRASION 2
197 CORNEAL OEDEMA 2
198 CORNEAL OPACITY 2
199 CORNEAL REFLEX DECREASED 2
200 CORNEAL TRANSPLANT 2
201 COVID-19 2
202 DARK CIRCLES UNDER EYES 2
203 DECREASED APPETITE 2
204 DEPRESSION 2
205 DERMATITIS CONTACT 2
206 DEVICE USE ISSUE 2
207 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2
208 DRUG INTERACTION 2
209 DRY SKIN 2
210 DYSPHONIA 2
211 EAR DISCOMFORT 2
212 EPIRETINAL MEMBRANE 2
213 EXTRA DOSE ADMINISTERED 2
214 EYELID RASH 2
215 EYELID RETRACTION 2
216 EYELID SENSORY DISORDER 2
217 FACIAL DISCOMFORT 2
218 FACIAL PARALYSIS 2
219 FEELING DRUNK 2
220 FIBROMYALGIA 2
221 FRUSTRATION TOLERANCE DECREASED 2
222 GIANT PAPILLARY CONJUNCTIVITIS 2
223 GLASSY EYES 2
224 HYPOAESTHESIA EYE 2
225 IMPAIRED QUALITY OF LIFE 2
226 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2
227 INCREASED APPETITE 2
228 INJURY CORNEAL 2
229 INTENTIONAL OVERDOSE 2
230 INTERNATIONAL NORMALISED RATIO INCREASED 2
231 IRIS DISCOLOURATION 2
232 JAW DISORDER 2
233 LETHARGY 2
234 LIP SWELLING 2
235 MACULAR OEDEMA 2
236 MASTICATION DISORDER 2
237 MYASTHENIA GRAVIS 2
238 NERVOUSNESS 2
239 OEDEMA PERIPHERAL 2
240 OPHTHALMIC MIGRAINE 2
241 OROPHARYNGEAL PAIN 2
242 PAIN OF SKIN 2
243 PARAESTHESIA ORAL 2
244 PERIORAL DERMATITIS 2
245 PHARYNGEAL SWELLING 2
246 PRODUCT DISPENSING ISSUE 2
247 PRODUCT ODOUR ABNORMAL 2
248 PRODUCT PRESCRIBING ISSUE 2
249 PRODUCT QUALITY ISSUE 2
250 PRODUCT STORAGE ISSUE 2
251 PRODUCT TEMPERATURE EXCURSION ISSUE 2
252 PUNCTATE KERATITIS 2
253 REBOUND EFFECT 2
254 RETINAL HAEMORRHAGE 2
255 SENSATION OF FOREIGN BODY 2
256 SINUS CONGESTION 2
257 SINUSITIS 2
258 SKIN SWELLING 2
259 SKIN WRINKLING 2
260 SNEEZING 2
261 SUPERFICIAL INJURY OF EYE 2
262 TASTE DISORDER 2
263 TONGUE DRY 2
264 ULCERATIVE KERATITIS 2
265 URINARY RETENTION 2
266 URINARY TRACT INFECTION 2
267 WEIGHT INCREASED 2
268 ABDOMINAL DISTENSION 1
269 ABDOMINAL PAIN 1
270 ACUTE SINUSITIS 1
271 ALOPECIA 1
272 ANAEMIA 1
273 ANAPHYLACTIC SHOCK 1
274 ANISOCORIA 1
275 ANTI-THYROID ANTIBODY INCREASED 1
276 ANTINUCLEAR ANTIBODY INCREASED 1
277 AORTIC VALVE REPLACEMENT 1
278 APPLICATION SITE ACNE 1
279 APPLICATION SITE DISCHARGE 1
280 APPLICATION SITE ERYTHEMA 1
281 APPLICATION SITE PAIN 1
282 APPLICATION SITE PRURITUS 1
283 APRAXIA 1
284 ARCUS LIPOIDES 1
285 ARRHYTHMIA 1
286 ARTHRITIS 1
287 ASTIGMATISM 1
288 AUDITORY DISORDER 1
289 AURA 1
290 AUTOIMMUNE NEUROPATHY 1
291 BACTERIAL INFECTION 1
292 BACTERIAL VAGINOSIS 1
293 BENIGN NEOPLASM OF EYE 1
294 BILIARY HAMARTOMA 1
295 BIPOLAR DISORDER 1
296 BLOOD BLISTER 1
297 BLOOD CHLORIDE INCREASED 1
298 BLOOD PHOSPHORUS DECREASED 1
299 BLOOD PRESSURE SYSTOLIC DECREASED 1
300 BLOOD THYROID STIMULATING HORMONE DECREASED 1
301 BLOOD THYROID STIMULATING HORMONE INCREASED 1
302 BLOOD UREA NITROGEN/CREATININE RATIO INCREASED 1
303 BLOOD URINE PRESENT 1
304 BONE PAIN 1
305 BRADYCARDIA 1
306 BREATH SOUNDS ABNORMAL 1
307 BRONCHITIS 1
308 BROW PTOSIS 1
309 BURNING SENSATION 1
310 BURSITIS 1
311 CARBON DIOXIDE DECREASED 1
312 CARDIAC FAILURE CONGESTIVE 1
313 CATARACT NUCLEAR 1
314 CEREBROVASCULAR ACCIDENT 1
315 CERUMEN IMPACTION 1
316 CHEMICAL BURN 1
317 CHEMOTHERAPY 1
318 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1
319 CONJUNCTIVAL CYST 1
320 CONJUNCTIVAL DISCOLOURATION 1
321 CONJUNCTIVAL OEDEMA 1
322 CONTACT LENS INTOLERANCE 1
323 COORDINATION ABNORMAL 1
324 CORNEAL IRRITATION 1
325 CORNEAL LACERATION 1
326 CORNEAL SCAR 1
327 CORONARY ARTERY BYPASS 1
328 CORONARY ARTERY OCCLUSION 1
329 CRYING 1
330 CUTANEOUS SYMPTOM 1
331 CYST 1
332 DEAFNESS NEUROSENSORY 1
333 DEATH 1
334 DECUBITUS ULCER 1
335 DEFAECATION URGENCY 1
336 DERMATITIS ALLERGIC 1
337 DEVICE ISSUE 1
338 DEVICE MATERIAL ISSUE 1
339 DISORIENTATION 1
340 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 1
341 DOSING ERROR 1
342 DRUG TOLERANCE INCREASED 1
343 DRUG USE DISORDER 1
344 DRY AGE-RELATED MACULAR DEGENERATION 1
345 DYSARTHRIA 1
346 DYSCHROMATOPSIA 1
347 DYSKINESIA 1
348 DYSPEPSIA 1
349 DYSSTASIA 1
350 EAR CONGESTION 1
351 EAR LOBE INFECTION 1
352 EAR PAIN 1
353 ENDOCRINE OPHTHALMOPATHY 1
354 ENERGY INCREASED 1
355 ENURESIS 1
356 EXTRAOCULAR MUSCLE PARESIS 1
357 EYE ALLERGY 1
358 EYE COMPLICATION ASSOCIATED WITH DEVICE 1
359 EYE INFECTION BACTERIAL 1
360 EYELASH CHANGES 1
361 EYELASH INJURY 1
362 EYELID INFECTION 1
363 EYELID INJURY 1
364 FACIAL SPASM 1
365 FEELING COLD 1
366 FEELING HOT 1
367 FLUID RETENTION 1
368 FLUSHING 1
369 FOOT FRACTURE 1
370 GASTROINTESTINAL DISORDER 1
371 GASTROINTESTINAL WALL THICKENING 1
372 GASTROOESOPHAGEAL REFLUX DISEASE 1
373 GENERALISED ANXIETY DISORDER 1
374 GLARE 1
375 GLYCOSYLATED HAEMOGLOBIN DECREASED 1
376 GLYCOSYLATED HAEMOGLOBIN INCREASED 1
377 GRANULOMA SKIN 1
378 GRAVES^ DISEASE 1
379 HAEMATOCHEZIA 1
380 HEAD DISCOMFORT 1
381 HEAD INJURY 1
382 HEART RATE DECREASED 1
383 HEART RATE IRREGULAR 1
384 HEPATIC CYST 1
385 HERPES VIRUS INFECTION 1
386 HIP FRACTURE 1
387 HYPERKERATOSIS 1
388 HYPERLIPIDAEMIA 1
389 HYPERTROPHY OF TONGUE PAPILLAE 1
390 HYPOACUSIS 1
391 HYPOGEUSIA 1
392 HYPOGLYCAEMIA 1
393 HYPONATRAEMIA 1
394 HYPOSMIA 1
395 IMPAIRED DRIVING ABILITY 1
396 IMPAIRED HEALING 1
397 IMPAIRED WORK ABILITY 1
398 INCREASED DOSE ADMINISTERED 1
399 INFLUENZA LIKE ILLNESS 1
400 INFUSION RELATED REACTION 1
401 INFUSION SITE DISCHARGE 1
402 INFUSION SITE EXTRAVASATION 1
403 INFUSION SITE HAEMORRHAGE 1
404 INFUSION SITE SCAB 1
405 INHIBITORY DRUG INTERACTION 1
406 INITIAL INSOMNIA 1
407 INJECTION SITE BRUISING 1
408 INJECTION SITE DISCOMFORT 1
409 INJECTION SITE SWELLING 1
410 INJURY ASSOCIATED WITH DEVICE 1
411 INSTILLATION SITE DISCOMFORT 1
412 INSTILLATION SITE FOREIGN BODY SENSATION 1
413 INTENTIONAL DOSE OMISSION 1
414 INTERVERTEBRAL DISC PROTRUSION 1
415 INTESTINAL DILATATION 1
416 INTESTINAL INFARCTION 1
417 INTRAOCULAR PRESSURE TEST ABNORMAL 1
418 IRIDOCYCLITIS 1
419 IRITIS 1
420 IRRITABILITY 1
421 JOINT SWELLING 1
422 KERATITIS 1
423 KERATOMILEUSIS 1
424 LAGOPHTHALMOS 1
425 LENTIGO 1
426 LIGAMENT SPRAIN 1
427 LIMB INJURY 1
428 LIP DRY 1
429 LOSS OF CONSCIOUSNESS 1
430 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1
431 LUMBAR VERTEBRAL FRACTURE 1
432 LUNG NEOPLASM MALIGNANT 1
433 MACULAR HOLE 1
434 MANDIBULAR MASS 1
435 MEAN CELL HAEMOGLOBIN INCREASED 1
436 MEAN CELL VOLUME INCREASED 1
437 MELANOCYTIC NAEVUS 1
438 MENINGITIS 1
439 MENSTRUAL DISORDER 1
440 MENTAL IMPAIRMENT 1
441 MESENTERIC CYST 1
442 MILIA 1
443 MUSCLE STRAIN 1
444 MUSCLE TWITCHING 1
445 MUSCULOSKELETAL STIFFNESS 1
446 MYALGIA 1
447 MYOCARDIAL INFARCTION 1
448 NASOPHARYNGITIS 1
449 NEOPLASM MALIGNANT 1
450 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 1
451 NEURALGIA 1
452 NIGHT SWEATS 1
453 NONINFECTIVE SIALOADENITIS 1
454 NONSPECIFIC REACTION 1
455 NOROVIRUS INFECTION 1
456 NYSTAGMUS 1
457 OESOPHAGITIS 1
458 ONYCHOLYSIS 1
459 OPHTHALMOPLEGIA 1
460 OPTIC ISCHAEMIC NEUROPATHY 1
461 ORAL CANDIDIASIS 1
462 PAIN IN EXTREMITY 1
463 PAIN IN JAW 1
464 PALLOR 1
465 PANIC REACTION 1
466 PERIORBITAL IRRITATION 1
467 PERIPHERAL SWELLING 1
468 PERIPHERAL VENOUS DISEASE 1
469 PHARYNGEAL PARAESTHESIA 1
470 POOR PERIPHERAL CIRCULATION 1
471 POOR QUALITY SLEEP 1
472 POST PROCEDURAL HAEMORRHAGE 1
473 POSTOPERATIVE WOUND INFECTION 1
474 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 1
475 POTENTIATING DRUG INTERACTION 1
476 PRECANCEROUS SKIN LESION 1
477 PRESCRIBED OVERDOSE 1
478 PRESCRIBED UNDERDOSE 1
479 PROCEDURAL PAIN 1
480 PRODUCT AFTER TASTE 1
481 PRODUCT CONTAINER ISSUE 1
482 PRODUCT DOSE OMISSION IN ERROR 1
483 PRODUCT DOSE OMISSION ISSUE 1
484 PRODUCT FORMULATION ISSUE 1
485 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1
486 PRODUCT PACKAGING DIFFICULT TO OPEN 1
487 PRODUCT RESIDUE PRESENT 1
488 PRODUCT USE COMPLAINT 1
489 PRODUCT USED FOR UNKNOWN INDICATION 1
490 PRODUCTIVE COUGH 1
491 PSYCHOMOTOR HYPERACTIVITY 1
492 PULMONARY OEDEMA 1
493 PUPILS UNEQUAL 1
494 QUADRANTANOPIA 1
495 QUALITY OF LIFE DECREASED 1
496 RASH ERYTHEMATOUS 1
497 RASH PAPULAR 1
498 RENAL CYST 1
499 RESPIRATION ABNORMAL 1
500 RESTLESS LEGS SYNDROME 1
501 RETCHING 1
502 RETINAL ANEURYSM 1
503 RETINAL OPERATION 1
504 RHEUMATOID ARTHRITIS 1
505 SARS-COV-2 TEST POSITIVE 1
506 SCAB 1
507 SCLERAL DISORDER 1
508 SCLERAL OEDEMA 1
509 SEBORRHOEIC KERATOSIS 1
510 SECRETION DISCHARGE 1
511 SEPTIC SHOCK 1
512 SIGHT DISABILITY 1
513 SINUS PAIN 1
514 SKIN BURNING SENSATION 1
515 SKIN CANCER 1
516 SKIN DISORDER 1
517 SKIN INDENTATION 1
518 SKIN LACERATION 1
519 SKIN MASS 1
520 SKIN REACTION 1
521 SLEEP APNOEA SYNDROME 1
522 SLEEP DISORDER 1
523 SLUGGISHNESS 1
524 SOMNAMBULISM 1
525 SOMNOLENCE 1
526 SPEECH DISORDER 1
527 SPINAL PAIN 1
528 SPONDYLOLISTHESIS 1
529 SQUAMOUS CELL CARCINOMA 1
530 STENT PLACEMENT 1
531 STRABISMUS 1
532 STRESS 1
533 SUBSTANCE USE DISORDER 1
534 SWOLLEN TEAR DUCT 1
535 TEAR DISCOLOURATION 1
536 TELANGIECTASIA 1
537 TEMPERATURE INTOLERANCE 1
538 TENDERNESS 1
539 TENDON RUPTURE 1
540 THERAPEUTIC RESPONSE DECREASED 1
541 THERAPY INTERRUPTED 1
542 THERMAL BURN 1
543 THROAT IRRITATION 1
544 THROAT TIGHTNESS 1
545 THROMBOCYTOPENIA 1
546 THYROID MASS 1
547 TIC 1
548 TONGUE DISCOMFORT 1
549 TRANSFERRIN SATURATION DECREASED 1
550 TRANSIENT ISCHAEMIC ATTACK 1
551 TREATMENT NONCOMPLIANCE 1
552 TRISMUS 1
553 TYPE 1 DIABETES MELLITUS 1
554 UPPER RESPIRATORY TRACT INFECTION 1
555 UPPER-AIRWAY COUGH SYNDROME 1
556 URINARY HESITATION 1
557 UVEITIS 1
558 VASCULAR CAUTERISATION 1
559 VEIN RUPTURE 1
560 VISUAL ACUITY REDUCED 1
561 VISUAL BRIGHTNESS 1
562 VISUAL FIELD DEFECT 1
563 VITAMIN D DECREASED 1
564 VITAMIN K DECREASED 1
565 VITREORETINAL TRACTION SYNDROME 1
566 VITREOUS DEGENERATION 1
567 VULVOVAGINAL DRYNESS 1
568 WOUND 1
569 WRONG DOSE 1